focus trial semaglutide Ozempic maker Novo Nordisk says it will study drug's effects on alcohol consumption but isn't focused on addiction Phase 3 Trial of Semaglutide

Current evidence shows no clinically significant cross-reactivity between these medication classes

10.1126/scitranslmed.3001845 Sci

Conclusions and Perspectives The mechanism through which some metals such as cadmium are able to produce human cancer and to generate oxidative stress, even if they cannot generate noxious free radicals through the general Fenton pathway, has so far escaped a chemically based explanation

I havent reached my target weight (close to it though), but the sickness was getting too much

Initially, injections may be given weekly or biweekly until levels improve, followed by maintenance doses every 1-3 months